Core Scientific Insider Plans $96k Share Sale Under Rule 144

Rhea-AI Filing Summary

Form 144 filed for Core Scientific, Inc. (CORZZ) discloses an intended sale of 7,759 common shares through Fidelity Brokerage Services on 06/25/2025 via the Nasdaq.

• Aggregate market value: $96,141.77
• Shares outstanding: 297,821,835 (sale represents ~0.003%)
• Source of shares: Restricted-stock vesting on 06/24/2025, received as compensation
• Seller’s recent activity: 57,921 shares sold in the prior three months, generating $675,328.06 in gross proceeds

The filing is a routine notice required under Rule 144 and does not, by itself, alter Core Scientific’s fundamentals. However, it documents additional insider liquidity actions that investors may monitor for context on executive trading trends.

Insights

Securities Analyst

TL;DR: Minor insider sale (0.003% of float) signals routine liquidity; negligible fundamental impact.

The Form 144 reveals a modest intended sale by an insider—7,759 shares valued at roughly $96k. Given the company’s 298 million shares outstanding, the transaction is immaterial to float and should have minimal price impact. Past three-month sales of 57,921 shares are still under 0.02% of shares outstanding, indicating no concentrated disposition. Investors typically watch insider activity for sentiment cues, but this scale is too small to infer strategic shifts. Rating the disclosure as neutral on valuation and governance grounds.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	7759	96141.77	297821835	06/25/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/24/2025	Restricted Stock Vesting	Issuer			7759	06/24/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Todd M. Duchene 838 Walker Road Suite 21-2105 Dover DE 19904	Common	04/01/2025	7921	59580.97
Todd M. Duchene 838 Walker Road Suite 21-2105 Dover DE 19904	Common	06/04/2025	50000	615747.09

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many Core Scientific (CORZZ) shares are being registered for sale under this Form 144?

The notice covers 7,759 common shares.

What is the aggregate market value of the shares listed in the filing?

The 7,759 shares have an aggregate market value of $96,141.77.

When is the proposed sale date for the shares?

The filing lists an approximate sale date of 06/25/2025.

What was the method of share acquisition disclosed in the Form 144?

Shares were acquired via restricted-stock vesting on 06/24/2025 as compensation.

How many shares has the insider sold over the past three months?

The seller disposed of 57,921 shares since April 2025, grossing $675,328.06.